13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-13, with 73 holding rows worth $962,154,050.
- Accession
- 0001420506-26-001563
- Filer
- CIK 1816307
- Filed
- 2026-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 73 entries on the cover page, a total value of $962,154,050 stated on the cover page (in dollars after the unit check, H1), rows summing to $962,154,050 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSilverArc Capital, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 206,234 | $55,006,732 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 500,996 | $52,414,202 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,280,707 | $49,563,361 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,301,979 | $47,912,827 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 2,017,009 | $42,740,421 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 390,000 | $38,017,200 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 311,461 | $34,581,515 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 352,802 | $33,576,166 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,108,295 | $26,820,739 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,214,390 | $26,546,565 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 489,382 | $24,836,137 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 619,096 | $23,853,769 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,263,026 | $23,138,636 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 2,927,698 | $22,631,106 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 169,593 | $22,599,963 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 65,679 | $21,988,672 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 546,256 | $21,282,134 | dollars as filed | |
| ARK ETF TR | 00214Q952 | GENOMIC REV ETF | 500,000 | $21,030,000 | dollars as filed | put |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 400,000 | $18,816,000 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 318,001 | $18,676,199 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F905 | COM | 693,600 | $15,162,096 | dollars as filed | call |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 99,826 | $14,976,895 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 3,032,060 | $14,159,720 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 509,789 | $12,938,445 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 678,095 | $12,646,472 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 1,177,821 | $12,532,015 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 5,744,757 | $11,891,647 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 95,000 | $11,679,300 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 186,821 | $11,276,516 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 330,487 | $10,879,632 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 48,101 | $10,392,702 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,946,482 | $10,296,890 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 3,472,737 | $10,140,392 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 500,402 | $9,247,429 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 679,826 | $9,096,072 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 145,000 | $8,428,850 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 122,269 | $8,393,767 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,355,459 | $8,349,627 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 3,101,129 | $8,342,037 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 738,873 | $8,001,995 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P909 | CALL | 682,600 | $7,392,558 | dollars as filed | call |
| MONTE ROSA THERAPEUTICS INC | 61225M902 | COM | 300,000 | $7,260,000 | dollars as filed | call |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 503,382 | $7,122,855 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 3,184,257 | $6,814,310 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 668,450 | $6,677,816 | dollars as filed | |
| ABIVAX SA | 00370M903 | CALL | 50,000 | $6,663,000 | dollars as filed | call |
| IBIO INC | 451033708 | CMN | 3,520,490 | $6,160,858 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 82,800 | $6,055,992 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 113,494 | $5,946,518 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 59,959 | $5,323,160 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 525,000 | $5,092,500 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 296,135 | $4,853,653 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 105,000 | $4,836,300 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 360,000 | $3,852,000 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 610,407 | $3,772,315 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 34,438 | $3,671,780 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 297,460 | $2,906,184 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575954 | PUT | 25,000 | $2,866,750 | dollars as filed | put |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 653,594 | $2,856,206 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 2,192,980 | $2,148,243 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 10,000 | $1,872,800 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 42,478 | $1,868,607 | dollars as filed | |
| ABSCI CORPORATION | 00091E959 | COM | 157,600 | $1,826,584 | dollars as filed | put |
| TELA BIO INC | 872381108 | COM | 2,137,201 | $1,602,901 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 227,178 | $1,483,472 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616909 | COM | 391,900 | $1,434,354 | dollars as filed | call |
| FRACTYL HEALTH INC | 35168W103 | COM | 1,637,976 | $1,301,208 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 545,000 | $1,297,100 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 59,104 | $1,063,872 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 321,728 | $894,404 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 45,975 | $224,358 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 224,360 | $146,193 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 104,828 | $356 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001563 | this filing | 2026-08-13 | acceptance time not in the bulk data set |